Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

https://www.soho2019.com/

 

Shifting Standard of Care for Frontline Therapy of CLL: Which Patients Benefit the Most from FCR, Ibrutinib Leads to Impressive PFS,What's the Ideal BCL2i Combo and Ideal Rx Duration?

421 views
October 18, 2019
Comments 0
Login to view comments. Click here to Login